Form 25-NSE KalVista Pharmaceuticals Filed by: Nasdaq Stock Market LLC
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stingray Indicates Delay in Filing of Its Audited Financial Statements and Applies for Voluntary Management Cease Trade Order
- Most Construction Firms Don’t Make It 10 Years. This Pensacola Company Just Hit 80.
- Cornelis and NextSilicon to Build Joint Reference Architectures for AI and HPC
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
